Two Indian American doctors honoured with professorships by Kansas Cancer Center

New Delhi: Two distinguished Indian American doctors of the University of Kansas Cancer Center were formally invested with endowed professorships that recognize the cancer center’s most productive faculty.

Breast medical oncologist Priyanka Sharma and gastroenterologist Prateek Sharma were honoured for their efforts in the research and treatment of cancer and gastroenterology.

Priyanka Sharma, MD, professor in the Department of Medical Oncology at the University of Kansas School of Medicine and co-leader of the cancer center’s Drug Discovery, Delivery and Experimental Therapeutics research program, was invested with the Frank B. Tyler Cancer Research Professorship.

Also Read: Padma Awardees who contributed to field of AYUSH honoured by Ministry

Breast medical oncologist, Dr Priyanka Sharma is a leading expert on triple-negative breast cancer. She has dedicated much of her career to identifying more effective therapies to treat this aggressive subtype of breast cancer. Dr Priyanka Sharma serves as vice chair for the breast committee of SWOG and is a member of the SWOG Board of Governors and National Cancer Institute (NCI) breast cancer steering committee.

Prateek Sharma, MD, professor of medicine and director of GI Fellowship Training at the University of Kansas School of Medicine, was invested with the Elaine Blaylock Cancer Research Professorship. Dr Prateek Sharma is a renowned gastroenterologist and scientist focusing on esophageal diseases, including cancer.

Currently, he is president-elect of the American Society for Gastrointestinal Endoscopy, serves as chair of the Esophageal Committee of the World Endoscopy Organization and chairs the American Society for Gastrointestinal Endoscopy artificial intelligence task force.

Both professorships are appointed positions made by Roy Jensen, MD, vice chancellor and director of The University of Kansas Cancer Center.“

Dr Priyanka and Prateek Sharma are outstanding leaders and experts in their respective fields,” Dr Jensen said. “Through these endowed chairs, both can pursue more innovative ideas and create more interdisciplinary collaborations leading to advances in cancer care.”

“Through these endowed chairs, both can pursue more innovative ideas and create more inter-disciplinary collaborations leading to advances in cancer care,” he added. 

The University of Kansas Cancer Center is the only National Cancer Institute (NCI)-designated comprehensive cancer center in the region, and one of only 53 in the nation, to receive this elite distinction.